Virtual Counseling for Tobacco Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people quit smoking by testing a virtual counseling program combined with community health worker support. Participants will receive a computerized intervention called C-Raven (an avatar-delivered computerized intervention for tobacco cessation) and guidance on lung cancer screening. The control group will wait six months before accessing the intervention. This study focuses on individuals living in low-income housing in Baltimore who have smoked more than 100 cigarettes in their lifetime and are considering quitting. Participants must speak English and plan to stay in their current home for nine months. As a Phase 4 trial, this research involves an FDA-approved treatment that has proven effective, aiming to understand how it benefits more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using medication to help quit smoking.
What is the safety track record for C-Raven?
Research shows that virtual programs like C-Raven, which help people quit smoking, are generally safe and easy to use. In past studies, treatments similar to C-Raven were tested and showed good results without major safety issues. Participants in these studies had positive experiences with the virtual counselor, who supported them in quitting smoking, along with help from community health workers.
Additionally, the nicotine replacement therapies included in the C-Raven program have been safely used for a long time to help people stop smoking. This combination of virtual counseling and nicotine aids is designed to be both effective and safe.
Since this trial is in a later stage, earlier studies have already checked C-Raven for safety. This stage usually focuses more on effectiveness rather than finding new safety problems. While no treatment is completely without risk, the evidence so far suggests that C-Raven is a safe choice for those wanting to quit smoking.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the virtual counseling for tobacco addiction because it offers a unique blend of personalized support and technology. Unlike traditional methods like nicotine replacement therapy or face-to-face counseling, this approach combines virtual counseling with community health worker support, making it more accessible and potentially more engaging. Additionally, it incorporates shared decision-making around lung cancer screening, which empowers participants and may enhance their commitment to quitting smoking. This comprehensive, tech-driven method could provide a more flexible and supportive path to cessation, reaching individuals who might not otherwise engage with traditional treatment options.
What evidence suggests that the C-Raven intervention is effective for tobacco cessation?
Studies have shown that virtual counseling can significantly help people quit smoking. Research indicates that a digital program called "Happy Ending" helped 22.3% of participants remain smoke-free long-term. In this trial, one group will receive C-Raven, the treatment under study, which is also a virtual program and includes support from community health workers. This combination aims to make quitting smoking easier and more successful. Although specific data on C-Raven's success is not yet available, it employs a similar approach to other effective digital programs.13678
Who Is on the Research Team?
Alejandra Ellison-Barnes, MD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals living in low-income housing units in Baltimore who are struggling with tobacco addiction or use disorder. Participants should be interested in quitting smoking and willing to engage with a virtual cessation program and potentially receive lung cancer screening.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial evaluation including demographics, clinical history, and tobacco use history
Treatment
Participants receive a virtual counselor intervention for smoking cessation and nicotine replacement therapies
Follow-up
Participants are monitored for smoking cessation outcomes and intervention acceptability
What Are the Treatments Tested in This Trial?
Interventions
- C-Raven
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Walgreens
Collaborator
Maryland Cigarette Restitution Fund
Collaborator
Walgreens
Industry Sponsor